Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

In vitro induction of carcinoembryonic antigen (CEA)-specific cytotoxic T lymphocytes by dendritic cells transduced with recombinant adenoviruses.

Vaccine - 12 Dec 2003

Cho Hyun-Il, Kim Hye-Jin, Oh Seoug-Taek, Kim Tai-Gyu

Abstract excerpt

Carcinoembryonic antigen (CEA), which is expressed in several cancer types, is a potential target for specific immunotherapy. In this study, the feasibility of using dendrite cells (DCs) for tumor immunotherapy after transduction with a recombinant adenovirus containing CEA gene (AdVCEA) was investigated. The recombinant AdV provided a highly efficient reproducible gene transfer into monocyte-derived DCs and its...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Adenoviridae
Share to Carcinoembryonic Antigen

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to CD56 Antigen

Share to CD8-Positive T-Lymphocytes

Share to Dendritic Cells

Share to Lymphocyte Subsets

Share to T-Lymphocytes, Cytotoxic

Share to Transduction, Genetic

Source

Identifiers

PMID: 14615150
DOI: 10.1016/s0264-410x(03)00569-3

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 6 Sept 2026. Manifest publication-graph-cohort-2026-09-06.1.

Source receipt: pubmed, retrieved 6 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

In vitro induction of carcinoembryonic antigen (CEA)-specific cytotoxic T lymphocytes by dendritic cells transduced with recombinant adenoviruses.PMID 14615150Read ↗

Comparison of three different methods of transfection for production of recombinant adenovirus vector expressing human carcinoembryonic antigen (CEA) geneSemantic proximity Read ↗

Clinical safety of induced CTL infusion through recombinant adeno-associated virus-transfected dendritic cell vaccination in Chinese cancer patients.Semantic proximity Read ↗

SLC gene-modified dendritic cells mediate T cell-dependent anti-gastric cancer immune responses in vitro.Semantic proximity Read ↗

Immunostimulatory virotherapy using recombinant Sendai virus as a new cancer therapeutic regimen.Semantic proximity Read ↗

Dendritic cells transfected with a polyepitope DNA construct stimulate an antitumor cytotoxic response in various tumor diseasesSemantic proximity Read ↗

Effective antitumor immunity against murine gliomas using dendritic cells transduced with hTERTC27 recombinant adenovirus.Semantic proximity Read ↗

HSP70L1-mediated intracellular priming of dendritic cell vaccination induces more potent CTL response against cancer.Semantic proximity Read ↗

In vitro anti-tumor immune response induced by dendritic cells transfected with recombinant adenovirus carrying mutant K-ras genes.Semantic proximity Read ↗

CD40ligand-expressing dendritic cells induce regression of hepatocellular carcinoma by activating innate and acquired immunity in vivo.Semantic proximity Read ↗

Dendritic cells transfected with adenoviral vectors as vaccines.Semantic proximity Read ↗

Transduction of dendritic cells with recombinant adenovirus encoding HCA661 activates autologous cytotoxic T lymphocytes to target hepatoma cells.Semantic proximity Read ↗

Dendritic cell-tumor fusion vaccine prevents tumor growth in vivo.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.